Loading stock data…
Creative Medical Technology Holdings (CELZ)
$0.81-0.39 (-32.48%)
Market ClosedLast close Jun 29
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Creative Medical Technology Holdings, Inc. in the Healthcare sector is trading at $0.81 with a market capitalization of $8M. Wall Street consensus targets $20.00 (1 analysts), implying a +2368.5% move over the next 12 months. The stock is currently near its 52-week low of $0.80, remaining 66.8% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 17 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +2368.5% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 17) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0↓ | $3,000 | $0 | $0↓ | $3,000 |
| Gross Profit | $0↓ | $2,006 | $0 | $0↓ | $1,800 |
| Operating Income | -$1.46M↑ | -$1.95M↓ | -$1.27M↓ | -$1.26M↑ | -$1.66M |
| Net Income | -$1.41M↑ | -$1.89M↓ | -$1.24M↓ | -$1.23M↑ | -$1.64M |
Peer Comparison
JNJUNHPFE
Fundamentals
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.24M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-94.31%
Volume
Today's trading volume
1.29M
Recent News
These Three Stocks Fell More Than 10% Today To Hit 52-Week Lows -- What's Driving The Investor Skepticism?
Creative Medical Technology, Baiya International Group, and GD Culture Group shares slumped to their 52-week lows amid divestiture and fundraising updates.
Creative Medical Technology opens nationwide burn-pit data registry
Creative Medical Technology Holdings Inc (NASDAQ:CELZ) has moved Project PHOENIX into a nationwide virtual data-collection phase, opening enrollment for a regulatory-approved registry that the company designed to support U.S. veterans exposed to burn pits and other toxic environmental...
Analysts Expect Breakeven For Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Before Long
Creative Medical Technology Holdings, Inc. ( NASDAQ:CELZ ) is possibly approaching a major achievement in its business...
Bears are Losing Control Over Creative Medical Technology Holdings, Inc. (CELZ), Here's Why It's a 'Buy' Now
Creative Medical Technology Holdings, Inc. (CELZ) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Market Sentiment Around Loss-Making Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ)
We feel now is a pretty good time to analyse Creative Medical Technology Holdings, Inc.'s ( NASDAQ:CELZ ) business as...